Cover Image
市場調查報告書

生殖技術市場(不孕:藥物及治療,避孕藥:藥物及設備):全球產業分析,規模,治療,市場佔有率,成長,趨勢,及預測

Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 299350
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生殖技術市場(不孕:藥物及治療,避孕藥:藥物及設備):全球產業分析,規模,治療,市場佔有率,成長,趨勢,及預測 Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年04月14日 內容資訊: 英文 125 Pages
簡介

本報告彙整支援生育管理所用的各種藥物,設備,及治療方法,提供市場趨勢,2013∼2019年的市場收益預測,參與企業簡介等,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 簡介及市場定義
  • 推動市場的要素
    • 避孕領域的遲滯
    • 不孕人口的增加
    • 全球肥胖蔓延
    • 抽煙,緊張狀態,污染等對生活方式的危害
    • 意外懷孕的增加未滿足避孕需求的女性的增加
    • 為了促進避孕產品,政府和NGO的配合
    • Patient Protection Act或Affordable Care Act的意願
  • 阻礙市場的要素
    • 保險對象的限制
    • 經濟,社會要素
    • 避孕藥及避孕設備的使用帶來的副作用
  • 市場機會
    • 醫療觀光的增加
    • 政府對治療不孕症的支援
    • 有穩定的避孕藥開發平台存在
  • 波特五力分析
  • 市場魅力度分析:各地區

第4章 不孕症治療別市場

  • 概要
  • 不孕治療藥
  • 不孕治療/輔助生育技術(ART)

第5章 避孕各技術市場

  • 概要
  • 避孕藥
    • 各類型市場收益
    • 口服藥丸市場
    • 注射劑市場
    • 局部避孕藥
  • 避孕設備
    • 各類型市場
    • 男性用設備
    • 女性用設備

第6章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他
    • 各技術市場收益
    • 市場收益(2011∼2019年)

第7章 建議

第8章 企業簡介

  • Abbott Laboratories, Inc.
  • Actavis, Inc.
  • Bayer AG
  • Church & Dwight, Co. Inc.
  • Cook Medical, Inc.
  • Ferring International Center S.A.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Merck Serono
  • Pfizer, Inc.
  • Reckitt Benckiser Group plc
  • Teva Pharmaceutical Industries Ltd.
  • Warner Chilcott plc

圖表

目錄

This report covers the market analysis for various drugs, devices and treatment technologies used in assistance and to control human reproduction. The stakeholders for this study include manufacturers and providers of contraceptive technologies and infertility solutions.

The market overview section of the report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global human reproductive technologies market.

The global human reproductive technologies market is categorized on the basis of various infertility treatments and contraceptive technologies. The infertility technologies market is analyzed in this report with respect to drugs as well as types of treatment procedures. With respect to drugs, the report includes leading brands (by sales) from three major classes, namely, gonadotropins, androgens and erectile dysfunction. The drug brands analyzed in this study include Gonal-f, Follistim AQ, AndroGel, Testim, Viagra, Cialis and Levitra/Staxyn. The market revenue and forecast for each brand has been provided for the period 2011 to 2019 in terms of USD million, along with the CAGR for the forecast period 2013 to 2019. The types of infertility treatment procedures studied in the report include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), zygote intrafallopian transfer (ZIFT), gamete intrafallopian transfer (GIFT) and intrauterine insemination (IUI). This section provides the global number of procedures performed historically for 2011 and 2012 along with the forecast for the period 2013 to 2019.

The contraceptive technologies market is classified into contraceptive drugs and devices. The contraceptive drugs market includes oral contraceptive pills, contraceptive injectables and topical contraceptives, while the contraceptive devices market is segmented into male contraceptive devices (condoms) and female contraceptive devices. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019. The market revenue has been forecast for the period 2013 to 2019, considering 2012 as the base year.

In terms of geographical distribution, the global human reproductive technologies market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section includes market revenue (2011 - 2019) and forecast (2013 - 2019) for the infertility treatment and contraceptive technologies markets in each regional market, in terms of USD million. The study further offers recommendations and highlights of the market, which would be useful for the present and new market players to sustain and grow in the global human reproductive technologies market.

This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include, Bayer Healthcare AG, Church & Dwight, Co. Inc., Boston Scientific Corporation, Ferring International Center S.A., Merck KGaA and Teva Pharmaceutical Industries, Ltd.

The global human reproductive technologies market is categorized into the following segments:

Human Reproductive Technologies Market, by Infertility Drugs

  • Gonal-f (recombinant follitropin alfa)
  • Follistim AQ (follitropin beta)
  • AndroGel (testosterone)
  • Testim (testosterone)
  • Viagra (sildenafil citrate)
  • Cialis (tadalafil)
  • Levitra/Staxyn (vardenafil)

Human Reproductive Technologies Market, by Infertility Procedures

  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Zygote Intrafallopian Transfer (ZIFT)
  • Gamete Intrafallopian Transfer (GIFT)
  • Intrauterine Insemination (IUI)

Human Reproductive Technologies Market, by Contraceptive Technologies

  • Drugs
    • Oral Contraceptive Pills
    • Contraceptive Injectables
    • Topical Contraceptives
  • Devices
    • Male Contraceptive Devices (Male Condoms)
    • Female Contraceptive Devices

Human Reproductive Technologies Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.4. Research Methodology
  • 1.5. List of Abbreviations

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Human Reproductive Technologies Market
  • 2.2. Comparative Analysis: Global Human Reproductive Technologies Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 - Market Overview

  • 3.1. Introduction and Market Definition
    • 3.1.1. Infertility Causative Factors
  • 3.2. Market Drivers
    • 3.2.1. Delay in Conception
    • 3.2.2. Rise in the Number of Infertile Population
    • 3.2.3. Increasing Prevalence of Worldwide Obesity
    • 3.2.4. Lifestyle Hazards such as Smoking, Stress and Pollution
    • 3.2.5. Rising Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs
    • 3.2.6. Government and NGO Initiatives to Promote Contraceptive Products
    • 3.2.7. Implementation of the Patient Protection Act or the Affordable Care Act
  • 3.3. Market Restraints
    • 3.3.1. Limited Insurance Coverage
    • 3.3.2. Economic and Social Factors
    • 3.3.3. Side Effects Associated with the Use of Contraceptive Drugs and Devices
  • 3.4. Market Opportunities
    • 3.4.1. Rise in Medical Tourism
    • 3.4.2. Government Support for Infertility Procedures
    • 3.4.3. Presence of Strong Contraceptives Pipeline
  • 3.5. Porter's Five Forces Analysis for the Global Human Reproductive Technologies Market
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Competitive Rivalry
  • 3.6. Market Attractiveness Analysis: Global Human Reproductive Technologies Market, by Geography

Chapter 4 - Global Human Reproduction Technologies Market, by Infertility Treatment

  • 4.1. Overview
  • 4.2. Infertility Drugs
    • 4.2.1. Global Infertility Drugs Market Revenue, by Brand, 2011 - 2019 (USD Million)
    • 4.2.2. Gonal-f
      • 4.2.2.1. Global Gonal-f Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.3. Follistim AQ
      • 4.2.3.1. Global Follistim AQ Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.4. AndroGel
      • 4.2.4.1. Global AndroGel Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.5. Testim
      • 4.2.5.1. Global Testim Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.6. Viagra
      • 4.2.6.1. Global Viagra Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.7. Cialis
      • 4.2.7.1. Global Cialis Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.8. Levitra/Staxyn
      • 4.2.8.1. Global Levitra/Staxyn Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Infertility Treatment/Assisted Reproductive Technologies (ART)
    • 4.3.1. Global Infertility Treatment/ART Procedures Market Forecast, by Procedures, 2011 - 2019 (Number of Procedures)
    • 4.3.2. In Vitro Fertilization (IVF)
      • 4.3.2.1. Global IVF Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
    • 4.3.3. Intracytoplasmic Sperm Injection (ICSI)
      • 4.3.3.1. Global ICSI Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
    • 4.3.4. Zygote Intrafallopian Transfer (ZIFT)
      • 4.3.4.1. Global ZIFT Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
    • 4.3.5. Gamete Intrafallopian Transfer (GIFT)
      • 4.3.5.1. Global GIFT Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
    • 4.3.6. Intrauterine Insemination (IUI)
      • 4.3.6.1. Global IUI Procedures Market Forecast, 2011 - 2019 (Number of Procedures)

Chapter 5 - Global Human Reproductive Technologies Market, by Contraceptive Technologies

  • 5.1. Overview
    • 5.1.1. Global Contraceptives Market Revenue, by Product Type, 2011 - 2019 (USD Million)
  • 5.2. Contraceptive Drugs
    • 5.2.1. Global Contraceptive Drugs Market Revenue, by Type, 2011 - 2019 (USD Million)
    • 5.2.2. Oral Contraceptive Pills
      • 5.2.2.1. Global Oral Contraceptive Pills Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.3. Contraceptive Injectables
      • 5.2.3.1. Global Contraceptive Injectables Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.4. Topical Contraceptives
      • 5.2.4.1. Global Topical Contraceptives Market Revenue, 2011 - 2019 (USD Million)
  • 5.3. Contraceptive Devices
    • 5.3.1. Global Contraceptive Devices Market Revenue, by Type, 2011 - 2019 (USD Million)
    • 5.3.2. Male Contraceptive Devices (Male Condoms)
      • 5.3.2.1. Global Male Contraceptive Devices (Male Condoms) Market Revenue, 2011 - 2019 (USD Million)
    • 5.3.3. Female Contraceptive Devices
      • 5.3.3.1. Global Female Contraceptive Devices Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Global Human Reproductive Technologies Market Revenue, by Geography

  • 6.1. Overview
  • 6.2. North America
    • 6.2.1. North America Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
    • 6.2.2. North America Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
    • 6.3.2. Europe Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Asia-Pacific
    • 6.4.1. Asia-Pacific Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
    • 6.4.2. Asia-Pacific Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. RoW Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
    • 6.5.2. RoW Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. Actavis, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. Bayer AG
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Church & Dwight, Co. Inc.
    • 8.4.1. Company Profile
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. Cook Medical, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Product Portfolio
    • 8.5.3. Business Strategies
    • 8.5.4. Recent Developments
  • 8.6. Ferring International Center S.A.
    • 8.6.1. Company Overview
    • 8.6.2. Product Portfolio
    • 8.6.3. Business Strategies
    • 8.6.4. Recent Developments
  • 8.7. Johnson & Johnson
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. Merck & Co., Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Merck Serono
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments
  • 8.10. Pfizer, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments
  • 8.11. Reckitt Benckiser Group plc
    • 8.11.1. Company Overview
    • 8.11.2. Financial Overview
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategies
    • 8.11.5. Recent Developments
  • 8.12. Teva Pharmaceutical Industries Ltd.
    • 8.12.1. Company Overview
    • 8.12.2. Financial Overview
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategies
    • 8.12.5. Recent Developments
  • 8.13. Warner Chilcott plc
    • 8.13.1. Company Overview
    • 8.13.2. Financial Overview
    • 8.13.3. Product Portfolio
    • 8.13.4. Business Strategies
    • 8.13.5. Recent Developments

List of Figures

  • FIG. 1: Human Reproductive Technologies Market Segmentation
  • FIG. 2: Global Human Reproductive Technologies Market, by Infertility Drugs, 2011 - 2019 (USD Million)
  • FIG. 3: Global Human Reproductive Technologies Market, by Infertility Treatment Procedures, 2012 (Number of Procedures)
  • FIG. 4: Comparative Analysis: Global Human Reproductive Technologies Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 5: Infertility Causative Factors: CDC, 2011 (%)
  • FIG. 6: Porter's Five Forces Analysis: Global Human Reproductive Technologies Market
  • FIG. 7: Market Attractiveness Analysis: Global Human Reproductive Technologies Market, by Geography
  • FIG. 8: Global Gonal-f Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9: Global Follistim AQ Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global AndroGel Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Global Testim Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Global Viagra Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Global Cialis Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: Global Levitra/Staxyn Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: Global IVF Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
  • FIG. 16: Global ICSI Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
  • FIG. 17: Global ZIFT Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
  • FIG. 18: Global GIFT Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
  • FIG. 19: Global IUI Procedures Market Forecast, 2011 - 2019 (Number of Procedures)
  • FIG. 20: Global Oral Contraceptive Pills Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21: Global Contraceptive Injectables Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22: Global Topical Contraceptives Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 23: Global Male Contraceptive Devices (Male Condoms) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24: Global Female Contraceptive Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25: North America Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 26: Europe Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 27: Asia-Pacific Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 28: RoW Human Reproductive Technologies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 29: Abbott Laboratories, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 30: Actavis, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 31: Bayer AG: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 32: Church & Dwight Co. Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 33: Johnson & Johnson: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 34: Merck & Co., Inc. (Pharmaceutical Division): Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 35: Merck Serono: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 36: Pfizer, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 37: Reckitt Benckiser Group plc: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 38: Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 39: Warner Chilcott plc: Annual Revenue, 2010 - 2011 (USD Million)

List of Tables

  • TABLE 1: List of Abbreviations
  • TABLE 2: Market Snapshot: Global Human Reproductive Technologies Market
  • TABLE 3: Side Effects Associated with the Use of Contraceptive Drugs and Devices
  • TABLE 4: Global Infertility Drugs Market Revenue, by Brand, 2011 - 2019 (USD Million)
  • TABLE 5: Global Infertility Treatment/ART Procedures Market Forecast, by Procedures, 2011 - 2019 (Number of Procedures)
  • TABLE 6: Global Contraceptives Market Revenue, by Product Type, 2011 - 2019 (USD Million)
  • TABLE 7: Global Contraceptive Drugs Market Revenue, by Type, 2011 - 2019 (USD Million)
  • TABLE 8: List of Latest Oral Contraceptive Pill Approvals, 2010 - 2012
  • TABLE 9: Global Contraceptive Devices Market Revenue, by Type, 2011 - 2019 (USD Million)
  • TABLE 10: North America Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 11: Europe Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 12: Asia-Pacific Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 13: RoW Human Reproductive Technologies Market Revenue, by Technology, 2011 - 2019 (USD Million)
Back to Top